| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Mattia Bonsignori | Q56808332 | ||
| David Easterhoff | Q89359808 | ||
| Kevin Wiehe | Q89359811 | ||
| Munir Alam | Q89520930 | ||
| Wilton B Williams | Q89520935 | ||
| P2093 | author name string | Thomas B Kepler | |
| R Ryan Meyerhoff | |||
| William J Faison | |||
| Todd Bradley | |||
| Kevin O Saunders | |||
| Connor Hart | |||
| P2860 | cites work | bNAber: database of broadly neutralizing HIV antibodies | Q24567758 |
| Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals | Q24635002 | ||
| Related Mechanisms of Antibody Somatic Hypermutation and Class Switch Recombination | Q27000758 | ||
| Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody | Q27644415 | ||
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus | Q27644501 | ||
| Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | Q27663293 | ||
| Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding | Q27670829 | ||
| Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 | Q27675879 | ||
| Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization | Q27677117 | ||
| Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies | Q27679353 | ||
| Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G | Q27704710 | ||
| H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination | Q28743596 | ||
| Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein | Q29306052 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| FLASH: fast length adjustment of short reads to improve genome assemblies | Q29615113 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Models of somatic hypermutation targeting and substitution based on synonymous mutations from high-throughput immunoglobulin sequencing data | Q30706182 | ||
| Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates | Q33612459 | ||
| Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies | Q33614365 | ||
| Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation | Q33654599 | ||
| Stepwise intraclonal maturation of antibody affinity through somatic hypermutation | Q33664973 | ||
| Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. | Q33693391 | ||
| Early development of broadly neutralizing antibodies in HIV-1-infected infants | Q33764917 | ||
| Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties | Q33814773 | ||
| Host controls of HIV broadly neutralizing antibody development | Q39108769 | ||
| Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection | Q39278529 | ||
| Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies | Q40118226 | ||
| Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. | Q40290521 | ||
| Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design | Q40679052 | ||
| Intraclonal generation of antibody mutants in germinal centres | Q41172275 | ||
| Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors | Q41818598 | ||
| Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation | Q44486460 | ||
| The nucleotide-replacement spectrum under somatic hypermutation exhibits microsequence dependence that is strand-symmetric and distinct from that under germline mutation | Q44872484 | ||
| Developing an HIV vaccine | Q47852386 | ||
| Immunologic memory to phosphocholine keyhole limpet hemocyanin. Recurrent mutations in the lambda 1 light chain increase affinity for antigen | Q52079184 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| Monitoring and interpreting the intrinsic features of somatic hypermutation | Q61628475 | ||
| Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline | Q34075820 | ||
| Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies | Q34114798 | ||
| Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies | Q34177732 | ||
| Germinal centers | Q34245271 | ||
| Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies | Q34392963 | ||
| Immunoglobulin somatic hypermutation | Q34638632 | ||
| The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection | Q35076717 | ||
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa | Q35140032 | ||
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors | Q35382871 | ||
| Dynamics of B cells in germinal centres | Q35446555 | ||
| HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies | Q35728947 | ||
| CATNAP: a tool to compile, analyze and tally neutralizing antibody panels | Q35810109 | ||
| Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages | Q35826158 | ||
| Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design | Q35868076 | ||
| Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire | Q35883727 | ||
| Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site | Q35943521 | ||
| HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen | Q35969973 | ||
| Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. | Q36112751 | ||
| Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots | Q36172034 | ||
| Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. | Q36290038 | ||
| Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection | Q36444787 | ||
| Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion | Q36559838 | ||
| Molecular mechanisms of antibody somatic hypermutation. | Q36747477 | ||
| Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies | Q36750045 | ||
| HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant | Q37059216 | ||
| Visualizing antibody affinity maturation in germinal centers | Q37078589 | ||
| Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages | Q37221575 | ||
| Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies | Q37246321 | ||
| HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies | Q37293480 | ||
| Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1. | Q38219407 | ||
| Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes | Q38388195 | ||
| Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires | Q38747466 | ||
| Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation | Q38988188 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 759-765.e6 | |
| P577 | publication date | 2018-05-31 | |
| P1433 | published in | Cell Host & Microbe | Q5058153 |
| P1476 | title | Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development. | |
| P478 | volume | 23 |
| Q95278620 | A facile technology for the high-throughput sequencing of the paired VH:VL and TCRβ:TCRα repertoires |
| Q90677040 | Antibody responses to the HIV-1 envelope high mannose patch |
| Q58781552 | Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design |
| Q93032892 | Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses |
| Q92727230 | Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting |
| Q102075551 | Eliciting B cell immunity against infectious diseases using nanovaccines |
| Q91413247 | Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology |
| Q92005460 | Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity |
| Q89790825 | Immune checkpoint modulation enhances HIV-1 antibody induction |
| Q91421247 | Immunological mechanisms of inducing HIV immunity in infants |
| Q60301098 | Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier |
| Q94590627 | Innovations in structure-based antigen design and immune monitoring for next generation vaccines |
| Q64053755 | Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage |
| Q93063721 | Lessons for general vaccinology research from attempts to develop an HIV vaccine |
| Q89548775 | Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization |
| Q96122822 | Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19 |
| Q90335423 | Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage |
| Q90044905 | VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage |
Search more.